Predictions
98 of 1,607 predictions match — page 1 of 2. Click any row to view its detail.
Filters
Domain
AllAIAI/AgentsAI/AGIAI/ArchitectureAI/ChinaAI/CognitionAI/ComputeAI/CorporateAI/FinanceAI/HardwareAI/InfrastructureAI/ManufacturingAI/MarketsAI/MathematicsAI/PhysicsAI/SoftwareAI/StartupsAI/StrategyAuto/TransportBiotech/LongevityCapital MarketsConsumerCryptoDefenseEconomyEconomy/OrgEducationEnergyEnergy/ComputeFinance/CryptoGeopoliticsInvestingLabor/JobsMacro/EconomyManufacturingMarkets/StocksMedia/AdsOtherPolicy/SemisQuantumQuantum/AIReal EstateRoboticsSemisSemis/ASICsSemis/GeopoliticsSemis/HardwareSemis/MarketsSemis/MemorySemis/PackagingSemis/Productsshort_horizon_breakoutSpaceSpace/ComputeTechnology
Predictor
| ID | Domain | Topic | Title | Predictor | Conv | SQ | Prior | Status | Window |
|---|---|---|---|---|---|---|---|---|---|
| IND_003 | Biotech/Longevity | NICU-4-hour-genomic-sequencing | Latency of medical truth actively collapsing — genomic sequencing for newborn… | Alex Wissner-Gross | 5/5 | C | 75.0% | in_progress | 2025-01-01 – 2026-11-30 |
| IND_012 | Biotech/Longevity | BioNeMo-Evo2-BRCA1-compression | NVIDIA BioNeMo platform + Evo 2 model fundamentally compresses a century of b… | Jensen Huang | 5/5 | A | 78.0% | in_progress | 2025-01-01 – 2030-06-30 |
| COD_BIO_001 | Biotech/Longevity | FDA-AI-drug-guidance | FDA finalizes or materially advances AI-for-drug-submission guidance by end 2026 | Codex Research Pack | 4/5 | — | 70.0% | pending | 2025-01-06 – 2026-12-31 |
| COD_BIO_002 | Biotech/Longevity | AI-drug-clinical | An AI-designed Isomorphic or peer drug enters or completes Phase 1 by end 2027 | Codex Research Pack | 3/5 | — | 50.0% | pending | 2025-03-31 – 2027-12-31 |
| 229_008 | Biotech/Longevity | humanoids | By end of 2026, Figure's robot hardware will be capable of performing what su… | Brett Adcock | 4/5 | C | 55.0% | pending | 2026-01-01 – 2026-09-30 |
| 233_014 | Biotech/Longevity | AI-scaling | Over the next 12 years, half of kids will have neural links while others won'… | Dave Blundin | 3/5 | C | 55.0% | pending | 2026-01-01 – 2038-11-30 |
| 235_027 | Biotech/Longevity | synbio | Longevity VC market expected to grow from $8.5B in 2024 to $12-18B in 2026. | Peter Diamandis | 4/5 | B | 65.0% | pending | 2026-01-01 – 2026-09-30 |
| 235_029 | Biotech/Longevity | synbio | Big pharma companies will transition into longevity business in next 3 years. | Peter Diamandis | 3/5 | C | 60.0% | pending | 2026-01-01 – 2029-11-30 |
| 242_048 | Biotech/Longevity | AI-scaling | FDA will move to zero clinical trial model given enough Bayesian/computationa… | Alex Wissner-Gross | 3/5 | C | 45.0% | pending | 2026-01-01 – 2031-09-30 |
| 245_014 | Biotech/Longevity | synbio | Colossal has major announcements coming this year with a local government on … | Ben Lamm | 4/5 | C | 50.0% | pending | 2026-01-01 – 2026-06-30 |
| 245_027 | Biotech/Longevity | synbio | Colossal DNA synthesis delivery will reach 20x the largest prior delivery by … | Ben Lamm | 4/5 | C | 50.0% | pending | 2026-01-01 – 2026-11-30 |
| 247_032 | Biotech/Longevity | AI-timing | Full cell simulation achievable within 5 years | Peter Diamandis | 3/5 | C | 60.0% | pending | 2026-01-01 – 2031-09-30 |
| 247_033 | Biotech/Longevity | AGI | Timelines for solving all disease are collapsing; Demis says cure all disease… | Demis Hassabis | 4/5 | C | 70.0% | pending | 2026-01-01 – 2036-06-30 |
| 247_034 | Biotech/Longevity | AI-timing | Dario Amodei said double human lifespan within the decade | Dario Amodei | 4/5 | B | 70.0% | pending | 2026-01-01 – 2036-11-30 |
| 247_041 | Biotech/Longevity | AI-timing | AI-powered drugs have 85% phase 1 success vs 52% traditional | Peter Diamandis | 4/5 | B | 65.0% | pending | 2026-01-01 – 2026-06-30 |
| 248_031 | Biotech/Longevity | AI-timing | Enhanced Games world records will accelerate on a scaling-law-style trajector… | Alex Wissner-Gross | 3/5 | C | 45.0% | pending | 2026-01-01 – 2026-09-30 |
| FUT_005 | Biotech/Longevity | Living-Intelligence-synthetic-biology | Emergence of 'Living Intelligence' 2026-2031: violent transformative converge… | Amy Webb | 5/5 | B | 55.0% | in_progress | 2026-01-01 – 2031-06-30 |
| FUT_019 | Biotech/Longevity | bio-industrial-circumvention-synthesis | Global market rapidly accelerates bio-industrial circumvention of fractured s… | Multi-Forecaster Synthesis | 4/5 | B | 35.0% | pending | 2026-01-01 – 2031-06-30 |
| IND_008 | Biotech/Longevity | biological-freedom-country-of-geniuses | 2026 era characterized as building a 'country of geniuses in a datacenter' — … | Dario Amodei | 5/5 | A | 35.0% | pending | 2026-01-01 – 2036-09-30 |
| IND_010 | Biotech/Longevity | Varda-orbital-pharma-factory-to-pharma | Autonomous orbital manufacturing (facilitated by companies like Varda Space I… | Jared Isaacman | 4/5 | B | 55.0% | in_progress | 2026-01-01 – 2026-09-30 |
| IND_020 | Biotech/Longevity | De-Novo-moment-gene-editing-100x | Massive 'rerating' of Biotech industry — by 2026, generative biology achieves… | Morgan Stanley | 5/5 | B | 40.0% | pending | 2026-01-01 – 2030-11-30 |
| INF_027 | Biotech/Longevity | drug-timeline-compression | AI infrastructure applied to structural biology will compress drug-developmen… | Demis Hassabis | 5/5 | A | 35.0% | pending | 2026-01-01 – 2036-06-30 |
| ROB_024 | Biotech/Longevity | global-BioVault-network | Automated robotics and AI-powered monitoring will establish a global network … | Ben Lamm | 4/5 | B | 52.0% | in_progress | 2026-01-01 – 2035-06-30 |
| ROB_025 | Biotech/Longevity | high-throughput-phenotyping | Genomic prediction will be entirely revolutionized by high-throughput phenoty… | Peter Dannenberg | 4/5 | C | 70.0% | in_progress | 2026-01-01 – 2032-11-30 |
| 235_038 | Biotech/Longevity | AI-timing | David Sinclair begins partial epigenetic reprogramming trials with Life Biosc… | Peter Diamandis | 5/5 | B | 92.0% | hit | 2026-03-01 – 2026-03-31 |
| 234_028 | Biotech/Longevity | AI-timing | Lab grown meat will replace conventional meat as the healthier environmental … | Peter Diamandis | 4/5 | B | 65.0% | pending | 2026-04-30 – 2031-12-31 |
| 238_044 | Biotech/Longevity | AI-timing | Mouse brain is 'next' for whole-brain emulation at Eon Systems | Alex Wissner-Gross | 4/5 | B | 50.0% | pending | 2026-04-30 – 2026-11-30 |
| 238_045 | Biotech/Longevity | AI-timing | Eon Systems aims to upload human minds to cyberspace as soon as possible | Alex Wissner-Gross | 4/5 | B | 50.0% | pending | 2026-04-30 – 2031-12-31 |
| 239_024 | Biotech/Longevity | AGI | Everyone on Earth will have better medical care than today's richest person | Elon Musk | 4/5 | B | 55.0% | pending | 2026-04-30 – 2028-11-30 |
| 239_025 | Biotech/Longevity | AGI | AI will solve back pain | Elon Musk | 3/5 | C | 50.0% | pending | 2026-04-30 – 2030-06-30 |
| 239_031 | Biotech/Longevity | synbio | Ben Lamb / Colossal could engineer a Pikachu-like creature | Ben Lamm | 3/5 | C | 45.0% | pending | 2026-04-30 – 2031-12-31 |
| 245_001 | Biotech/Longevity | AI-timing | Synthetic biology paired with AI will be the most transformative technology i… | Ben Lamm | 4/5 | C | 50.0% | pending | 2026-04-30 – 2035-12-31 |
| 245_005 | Biotech/Longevity | synbio | Countries will become customers to preserve endangered species via Colossal | Peter Diamandis | 3/5 | C | 60.0% | pending | 2026-04-30 – 2030-12-31 |
| 245_006 | Biotech/Longevity | synbio | Colossal will productionize species development via biobanking, synthetic bio… | Ben Lamm | 3/5 | C | 45.0% | pending | 2026-04-30 – 2030-12-31 |
| 245_007 | Biotech/Longevity | synbio | Colossal will bring back the woolly mammoth | Ben Lamm | 4/5 | C | 50.0% | pending | 2026-04-30 – 2028-12-31 |
| 245_008 | Biotech/Longevity | AI-timing | More direwolves will be produced after initial Romulus and Remus | Ben Lamm | 4/5 | C | 50.0% | partial | 2026-04-30 – 2027-12-31 |
| 245_009 | Biotech/Longevity | AI-timing | Breaking plastic-degradation technology could become a supplement that breaks… | Peter Diamandis | 3/5 | C | 60.0% | pending | 2026-04-30 – 2027-09-30 |
| 245_010 | Biotech/Longevity | AI-timing | Breaking will pursue a human-body microplastic solution (supplement) in addit… | Ben Lamm | 3/5 | C | 45.0% | pending | 2026-04-30 – 2029-12-31 |
| 245_011 | Biotech/Longevity | synbio | Colossal is spinning out a dozen companies each with massive potential | Peter Diamandis | 4/5 | B | 65.0% | pending | 2026-04-30 – 2028-12-31 |
| 245_012 | Biotech/Longevity | synbio | UAE's Biovault is a nine-figure initiative for both Colossal and the UAE | Ben Lamm | 5/5 | C | 92.0% | hit | 2026-04-30 – 2028-11-30 |
| 245_013 | Biotech/Longevity | AI-timing | Artificial wombs will eventually enable productionized de-extinction species | Ben Lamm | 3/5 | C | 45.0% | pending | 2026-04-30 – 2032-12-31 |
| 245_015 | Biotech/Longevity | synbio | Colossal could theoretically create Pikachu (engineer novel designer organisms) | Ben Lamm | 3/5 | C | 45.0% | pending | 2026-04-30 – 2032-12-31 |
| 245_016 | Biotech/Longevity | autonomous | Kitrid disease is the leading extinction driver in frogs/amphibians and can b… | Ben Lamm | 4/5 | C | 50.0% | pending | 2026-04-30 – 2030-12-31 |
| 245_021 | Biotech/Longevity | AI-timing | Engineered all-male screworms released via gene drive will cause species die-… | Ben Lamm | 4/5 | C | 50.0% | pending | 2026-04-30 – 2029-12-31 |
| 245_026 | Biotech/Longevity | synbio | Colossal editing tech will be applicable to human healthcare (spun out/licensed) | Ben Lamm | 3/5 | C | 45.0% | pending | 2026-04-30 – 2030-12-31 |
| 245_029 | Biotech/Longevity | synbio | IVF will be transformed by Colossal's hydrogel/microfluidics embryo tech and … | Ben Lamm | 3/5 | C | 45.0% | pending | 2026-04-30 – 2029-12-31 |
| 245_030 | Biotech/Longevity | AI-timing | Humans will need to use synthetic biology to help species adapt faster than e… | Ben Lamm | 4/5 | C | 50.0% | pending | 2026-04-30 – 2031-12-31 |
| 245_033 | Biotech/Longevity | synbio | Colossal will work to reintroduce all de-extincted species back into their en… | Ben Lamm | 4/5 | C | 50.0% | pending | 2026-04-30 – 2030-12-31 |
| 245_036 | Biotech/Longevity | synbio | Colossal will continue seeding and spinning out new companies from scientific… | Ben Lamm | 4/5 | C | 50.0% | pending | 2026-04-30 – 2028-12-31 |
| 245_037 | Biotech/Longevity | AGI | Mosquito gene drive halted in Africa was possibly wrong to stop since mosquit… | Ben Lamm | 3/5 | C | 45.0% | pending | 2026-04-30 – 2040-09-30 |